newsfilter
← Latest News
PR Newswire·

Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer

Becomes the 7th International Registrational Clinical Trial for IvonescimabClinical Trial Site Activations in the United States Expected to Begin Q4 2026HONG KONG, Oct. 21, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: